Overview

The Effect of IM Testosterone Undecanoate on Biochemical and Anthropometric Characteristics of Metabolic Syndrome in Hypogonadal Men

Status:
Unknown status

Trial end date:
2010-12-01

Target enrollment:

Participant gender:

Summary

The objective of the study is to assess the effect of the testosterone therapy on the body composition, lipid and glucose metabolism, inflammatory markers in patients with metabolic syndrome and hypogonadism.

Phase:

Phase 3

Details

Lead Sponsor:

Russian Academy of Medical Sciences

Treatments:

Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate